Stocks and Investing
Stocks and Investing
Mon, March 19, 2012
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:40 AM ] - WOPRAI
[ 07:02 AM ] - WOPRAI
[ 07:02 AM ] - WOPRAI
[ 07:01 AM ] - WOPRAI
[ 07:01 AM ] - WOPRAI
[ 07:00 AM ] - WOPRAI
[ 07:00 AM ] - WOPRAI
[ 06:00 AM ] - Market Wire
[ 06:00 AM ] - Market Wire
[ 05:44 AM ] - Market Wire
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 05:40 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Harrison Downgraded (VRTX) to Sell and Held Target at $30 on, Mar 19th, 2012
Matthew Harrison of Morgan Stanley, Downgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Sell and Held Target at $30 on, Mar 19th, 2012.
Matthew has made no other calls on VRTX in the last 4 months.
There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $49 on, Wednesday, March 14th, 2012